Eli Lilly and Company

CYRAMZA

  1. Home
  2.  / 
  3. J Code
  4.  / CYRAMZA – J9308

Manufacturer:

Eli Lilly and Company

Name:

CYRAMZA

HCPCS Code Descriptor:

Injection, ramucirumab, 5 mg

Category:

J Code

HCPCS:

J9308

NDC(s):

00002-7678-01, 00002-7669-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

CYRAMZA is an Oncology drug manufactured by Eli Lilly and Company and administered via the Intravenous route of administration. The J Code: J9308 is aligned to the drug CYRAMZA.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/16

HCPCS Effective Date:

1/1/16

HCPCS Short Description:

Injection, ramucirumab

Billing and Coding Guide:

https://www.cyramza.com/assets/pdf/cyramza-billing-coding.pdf

Patient Assistance:

http://www.lillycares.com

CYRAMZA - J9308